N-p-Tolylmethanesulfonamide

Catalog No.: 
ACORAC302
CAS No.: 
4284-47-3
Molecular Formula: 
C8H11NO2S
Molecular Weight: 
185.25
N-p-Tolylmethanesulfonamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$104.00In stockIn stock
5g95%$311.00In stockInquiry
25g95%$1232.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-p-Tolylmethanesulfonamide
IUPAC NameN-(p-tolyl)methanesulfonamide
MDL No.MFCD01213106
Molecular FormulaC8H11NO2S
Molecular Weight185.25
SMILESCS(=O)(NC1=CC=C(C)C=C1)=O
InChI KeyJSSIRQJITXDDGR-UHFFFAOYSA-N
SynonymN-(4-methylphenyl)methanesulfonamide;Methanesulfonamide, N-(4-methylphenyl)-
CAS No.4284-47-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P264-P270-P301+P312-P330-P501

Synthetic Route by SureRoute

1. ACORAC302 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKNFW847 route compound structure diagram
    ACKNFW8473144-09-0In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACORAC302 route product structure diagram
    ACORAC3024284-47-3In Stock
Inquiry

2. ACORAC302 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKNFW847 route compound structure diagram
    ACKNFW8473144-09-0In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. ACWTIE108 route compound structure diagram
    ACWTIE108131651-65-5
  6. Then
  7. ACORAC302 route product structure diagram
    ACORAC3024284-47-3In Stock
Inquiry

3. ACORAC302 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACORAC302 route product structure diagram
    ACORAC3024284-47-3In Stock
Inquiry

Comments (0)